Previous studies have reported high expression of CDH17 in normal colon tissues, suggesting that it may not be a suitable target for GI tumors.[11, 13] However, in our study, we did not observe enrichment of Nb289 nanobody in colon tissues, despite Nb289 exhibiting good affinity to murine CDH17. Here, CDH17 is linked to digestive system neoplasm.